DANBURY, Conn., Feb. 4, 2014 (GLOBE NEWSWIRE) -- Biodel Inc. (Nasdaq:BIOD) announced today that it will present at the following upcoming conferences:
- February 7, 2014, 1:22 p.m. Central European Time: Biodel will be presenting "Novel Formulations to Modify Mealtime Insulin Kinetics" in the Mealtime Insulin Industry Session at the 7th International Conference on Advanced Technologies & Treatments for Diabetes in Vienna, Austria. Concurrent with the presentation, slides will be available in the News & Events section of the Biodel website, www.biodel.com
- February 11, 2014, 3:30 p.m. U.S. Eastern Standard Time: Biodel management will be presenting an overview of the Company's technologies, development programs, and outlook at the 16th Annual BIO CEO & Investor Conference at the Waldorf Astoria in New York, NY. Interested parties can access a link to a live webcast of the presentation from the News & Events section of the Biodel website, www.biodel.com. Replays of the presentation will be available for 90 days.
About Biodel Inc.
Biodel Inc. is a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for diabetes that may be safer, more effective and more convenient for patients. Biodel's product candidates are developed by applying proprietary technologies to existing drugs in order to improve their therapeutic profiles. More information about Biodel is available at www.biodel.com.
CONTACT: John Graziano, +1 (646) 378 2942
Source: Biodel Inc.